Compounds > 7-hydroxy-2-n,n-dipropylaminotetralin
Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Electrocardiogram QT Prolonged

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Electrocardiogram QT Prolonged in 1 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Torres-Jácome, J1
Tejeda-Chávez, HR1
Rodríguez-Menchaca, AA1
Sánchez-Chapula, JA1
Navarro-Polanco, RA1

Other Studies

1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Electrocardiogram QT Prolonged

ArticleYear
The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K+ channel.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5

    Topics: Action Potentials; Animals; Cats; Cell Line; Dopamine Agonists; ERG1 Potassium Channel; Ether-A-Go-G

2006